Skip to content

A Comparative Clinical Study Of two oral drugs Shatapushpa Churṇa And Chaturbeeja Churṇa In The Management Of PCOS Polycystic Ovarian Syndrome

A Randomized Comparative Clinical Study Of Shatapushpa Churṇa And Chaturbeeja Churṇa In The Management Of Nashtartava With Special Reference To Polycystic Ovarian Syndrome

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018364
Enrollment
100
Registered
2019-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N91- Absent, scanty and rare menstruation

Interventions

Intervention1: Shatapushpa Churṇa: 5 grams orally mixed wuth Ghrita with Lukewarm water Bhojana Pūrva and twice a day for 2 months/60 consecutive days Control Intervention1: Chaturbeeja Churṇa:

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor
department of AYUSH
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Presence of any two of the following three criteria Patients age 18 â?? 45 years and (ASRM/ESHRE,2003) Oligo and /or anovulation Hyper-androgenism(clinical and /or biochemical). Polycystic ovaries.

Exclusion criteria

Exclusion criteria: Pregnant women. Patients with chronic systemic illness (Congestive cardiac failure, Hypertension, cirrhosis of liver, chronic renal disease, uncontrolled diabetes mellitus etc.). Patients using oral contraceptive pills. Patients with any organic reproductive system abnormalities (Excluded clinically and radiologically), pelvic inflammatory disease, hydrosalpinx, endometriosis, adenomyosis, fibroid uterus, carcinoma of reproductive organ.. Any type of malignancy. Positive STDs, HIV, HBsAg. Patients suffering from adrenal hyperplasia, severe insulin resistance, androgen secreting neoplasm, thyroid abnormalities, Cushingâ??s syndrome.

Design outcomes

Primary

MeasureTime frame
relief in symptoms of PCOSTimepoint: relief in symptoms in 60 days

Secondary

MeasureTime frame
relief from PCOSTimepoint: 60 days

Countries

India

Contacts

Public Contactsusheela choudhary

National Institute of Ayurveda Jaipur

choudhary.sush.08@gmail.com9667166472

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026